The Beauty Health Company (SKIN) Prices Upsized $650M Convertible Offering of Senior Notes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Pre-Open Stock Movers 09/09: (CURV) (CRDF) (LULU) Higher; (BASE) (SAM) (GME) Lower (more...)
September 9, 2021 9:29 AM EDTPre-Open Stock Movers:
Couchbase, Inc. (NASDAQ: BASE) 16.3% LOWER; reported Q2 EPS of ($1.54). Revenue for the quarter came in at $29.7 million. Couchbase, Inc. sees FY2022 revenue of $120.8-121.2 million, versus the consensus of $118 million.
Torrid Holdings Inc. (NYSE: CURV) 16% HIGHER; reported Q2 EPS of $0.35, $0.26 better than the analyst estimate of $0.09. Revenue for the quarter came in at $332.9 million versus the consensus estimate of $277.83 million. Torrid... More
After-Hours Stock Movers 09/08: (CRDF) (PRQR) (LULU) Higher; (SAM) (ABM) (GME) Lower (more...)
September 8, 2021 6:12 PM EDTAfter-Hours Stock Movers:
Cardiff Oncology, Inc. (Nasdaq: CRDF) 21.6% HIGHER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC).
ProQR Therapeutics N.V. (Nasdaq: PRQR) 21% HIGHER; today announced a global licensing and research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system.... More
The Beauty Health Company (SKIN) Announces Proposed Convertible Senior Notes Offering
September 8, 2021 4:14 PM EDTThe Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ: SKIN) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amount of convertible senior notes due 2026 (the notes) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). BeautyHealth also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $60,000,000... More



